Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Ralf Badur has worked on the following 12 EPO patent applications which have been published in the last five years:

EP11784717

MULTISPECIFIC MOLECULES

IPC classification:
C07K 16/28, C07K 16/32
Applicant:
Novartis AG
Agent:
Ralf Badur, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14163854

Short interfering ribonucleic acid (siRNA)

IPC classification:
A61K 31/712, A61K 31/713, C12N 15/113
Applicant:
Novartis AG
Agent:
D Young & Co LLP
Agent:
Ralf Badur, Novartis Pharma AG
Status:
PATENT GRANTED
EP14163856

Short interfering ribonucleic acid (siRNA)

IPC classification:
C12N 15/113
Applicant:
Novartis AG
Agent:
Ralf Badur, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14163857

Short interfering ribonucleic acid (siRNA)

IPC classification:
A61K 31/00, C12N 15/113
Applicant:
Novartis AG
Agent:
Ralf Badur, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13729859

SITE-SPECIFIC LABELING METHODS AND MOLECULES PRODUCED THEREBY

IPC classification:
A61K 47/48, C07K 7/06, C07K 7/08, C07K 16/00, C07K 16/32, C12N 9/10
Applicant:
Novartis AG
Agent:
Ralf Badur, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13828987

STABILIZED INSULIN-LIKE GROWTH FACTOR POLYPEPTIDES

IPC classification:
C07K 14/65
Applicant:
Novartis AG
Agent:
Ralf Badur, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11715243

ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES

IPC classification:
A61K 31/713, A61P 3/12, C12N 15/113
Applicant:
Novartis AG
Agent:
Adriaan van Kooij, Arnold & Siedsma B.V.
Agent:
Ralf Badur, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14802490

INSULIN-LIKE GROWTH FACTOR MIMETICS FOR USE IN THERAPY

IPC classification:
A61K 38/30, A61P 21/00
Applicant:
Novartis AG
Agent:
Ralf Badur, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP15157068

FLAVIVIRUS REPLICONS

IPC classification:
C12N 15/86
Applicant:
Novartis AG
Agent:
Ralf Badur, Novartis Pharma AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION PUBLISHED
EP14831080

A PROCESS FOR PREPARING A COMPOSITION OF PEGYLATED PROTEINS

IPC classification:
A61K 47/48, C07K 14/65
Applicant:
Novartis AG
Applicant:
LEK Pharmaceuticals dd
Agent:
Ralf Badur, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP16184724

METHODS AND COMPOSITIONS USING FGF23 FUSION POLYPEPTIDES

IPC classification:
C12N 15/62, G01N 33/574, G01N 33/68
Applicant:
Novartis AG
Agent:
Ralf Badur, Novartis Pharma AG
Status:
APPLICATION PUBLISHED
EP16202193

IMPROVED FIBRONECTIN-BASED BINDING MOLECULES AND USES THEREOF

IPC classification:
C07K 14/78, C07K 16/00
Applicant:
Novartis AG
Agent:
Ralf Badur, Novartis Pharma AG
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature